Popular pages

• Technology platform

  Technology platform Technology platform PharmAbs clusters unique expertise in antibody generation, selection, production, characterisation, humanisation and tailor-made engineering combined with prove...

• Activities

  Activities R&D co-development projects with academic research groups and companies. Our core expertise is antibody-based therapeutic lead products antibody-based immunoassays generation of tailor-mad...

• Mission

  Mission Mission It is our mission to bridge discovery and valorization with antibodies. It is the objective of PharmAbs to support academic groups and biotech companies in creating value for their pro...

• Founders

  Founders Founders PharmAbs clusters the expertise in antibody generation, selection, production, characterisation, humanisation and tailor-made engineering of the following KU Leuven R&D groups: ►

• Meet the team

  #comments .form-submit #submit, .search-block .search-submit, .side-aligned-social a.header-social-icon, .no-results-btn, button, ...

• Partnering & investors

  Partnering & investors   Plasminogen activators are the only thrombolytic agents approved to rapidly revascularize a thrombosed vessel. Reperfusion of the ischemia-affected organ leads to an improved ...